Franklin Biotechnology Discovery Fund Advisor Class
FTDZX
NASDAQ
| Weiss Ratings | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Company Info | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Franklin Templeton Investments | |||
| Manager/Tenure (Years) | Evan S. McCulloch (28), Akiva Felt (6) | |||
| Website | http://www.franklintempleton.com | |||
| Fund Information | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Franklin Biotechnology Discovery Fund Advisor Class | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Sep 01, 2009 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 100,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 1.96% | |||
| Dividend | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.38% | |||
| Asset Allocation | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 4.23% | |||
| Stock | 95.16% | |||
| U.S. Stock | 85.67% | |||
| Non-U.S. Stock | 9.49% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.61% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -5.39% | |||
| 30-Day Total Return | 5.75% | |||
| 60-Day Total Return | -1.08% | |||
| 90-Day Total Return | 1.04% | |||
| Year to Date Total Return | 2.33% | |||
| 1-Year Total Return | 61.72% | |||
| 2-Year Total Return | 56.21% | |||
| 3-Year Total Return | 84.29% | |||
| 5-Year Total Return | 46.31% | |||
| Price | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $179.92 | |||
| 1-Month Low NAV | $170.13 | |||
| 1-Month High NAV | $194.87 | |||
| 52-Week Low NAV | $110.33 | |||
| 52-Week Low NAV (Date) | May 09, 2025 | |||
| 52-Week High NAV | $196.91 | |||
| 52-Week High Price (Date) | Nov 28, 2025 | |||
| Beta / Standard Deviation | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.76 | |||
| Standard Deviation | 20.31 | |||
| Balance Sheet | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 1.02B | |||
| Operating Ratios | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.77% | |||
| Turnover Ratio | 21.87% | |||
| Performance | FTDZX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 63.50% | |||
| Last Bear Market Total Return | -11.75% | |||